rasH2 Publications

rasH2 Model Page

Filter publications by application: All ADMET Tox & Safety Assessment
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Saitoh A, et al.
Mouse over for full list
Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, Katsuki M
(1990) Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5(8):1195-200
Paranjpe MG, et al.
Mouse over for full list
Paranjpe MG, Belich JL, Richardson DR, Vidmar T, Mann PC, McKeon ME, Elbekai RH
(2016) Progression of Serosal Vascular Proliferative Lesions to Hemangiosarcomas in the Uterus of the 26-Week Tg.rasH2 Mice Carcinogenicity Studies. Int. J. Toxicol.
ADMET, Tox & Safety Assessment
Yamamoto S, et al.
Mouse over for full list
Yamamoto S, Urano K, Nomura T
(1998) Validation of transgenic mice harboring the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Toxicol. Lett. 102-103:473-8
Yamamoto S, et al.
Mouse over for full list
Yamamoto S, Mitsumori K, Kodama Y, Matsunuma N, Manabe S, Okamiya H, Suzuki H, Fukuda T, Sakamaki Y, Sunaga M, Nomura G, Hioki K, Wakana S, Nomura T, Hayashi Y
(1996) Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 17(11):2455-61
Usui T, et al.
Mouse over for full list
Usui T, Mutai M, Hisada S, Takoaka M, Soper KA, McCullough B, Alden C
(2001) CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol 29 Suppl:90-108
Urano K, et al.
Mouse over for full list
Urano K, Suzuki S, Machida K, Sawa N, Eguchi N, Kikuchi K, Fukasawa K, Taguchi F, Usui T
(2006) Use of IC tags in short-term carcinogenicity study on CB6F1 TGrasH2 mice. J Toxicol Sci 31(5):407-18
Takegawa K, et al.
Mouse over for full list
Takegawa K, Mitsumori K, Yasuhara K, Moriyasu M, Sakamori M, Onodera H, Hirose M, Nomura T
(2000) A mechanistic study of ovarian carcinogenesis induced by nitrofurazone using rasH2 mice. Toxicol Pathol 28(5):649-55
Suemizu H, et al.
Mouse over for full list
Suemizu H, Muguruma K, Maruyama C, Tomisawa M, Kimura M, Hioki K, Shimozawa N, Ohnishi Y, Tamaoki N, Nomura T
(2002) Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Mol. Carcinog. 34(1):1-9
Ohnishi Y, et al.
Mouse over for full list
Ohnishi Y, Arai T, Koshirakawa M, Horii N, Nakajo S, Urano K, Usui T, Tamaoki N, Ueyama Y
(2001) Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrying human prototype c-Ha-ras gene and their wild type littermates. Exp. Anim. 50(1):33-9
Morton D, et al.
Mouse over for full list
Morton D, Alden CL, Roth AJ, Usui T
(2002) The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 30(1):139-46
Mitsumori K, et al.
Mouse over for full list
Mitsumori K, Koizumi H, Nomura T, Yamamoto S
(1998) Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 26(4):520-31
Maronpot RR, et al.
Mouse over for full list
Maronpot RR, Mitsumori K, Mann P, Takaoka M, Yamamoto S, Usui T, Okamiya H, Nishikawa S, Nomura T
(2000) Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model. Toxicology 146(2-3):149-59
Kanno H, et al.
Mouse over for full list
Kanno H, Tanakamaru ZY, Ishimura Y, Kandori H, Yamasaki H, Sasaki S
(2003) Historical Background Data in CB6F1-Tg-rasH2 Mice and CB6F1-nonTg-rasH2 Mice over a 26-Week Experimental Period J Toxicol Pathol. 16(4):267-274
Gulezian D, et al.
Mouse over for full list
Gulezian D, Jacobson-Kram D, McCullough CB, Olson H, Recio L, Robinson D, Storer R, Tennant R, Ward JM, Neumann DA
(2000) Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment. Toxicol Pathol 28(3):482-99